Food & Drug Administration (FDA) determined that the shortage of the tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved and removed from the FDAs shortage list, see our prior blog GLP-1 Drugs: FDA Removes Lillys Zepbound and Mounjaro (tirzepatide injection) from its Drug Shortage List, on October 8, 2024, the Outsourcing Facilities Association (OFA) a trade association representing FDA-registered 503B outsourcing facilities filed a lawsuit against the FDA relating to the agencys removal of tirzepatide, from the FDAs drug shortage list
Finally, to gain initial insight regarding the interaction site for TBC1D9B within TMEM55B, we examined the AlphaFold2 model of TMEM55B (Supplementary Fig
Ellagic acid protects against diabetes-associated behavioral deficits in rats: possible involved mechanisms
rather, it helps to balance hormones and energy metabolism under stress
FOXO transcription factors, particularly FOXO4, play a crucial role in regulating cellular mechanisms associated with longevity and tissue protection against damage